Evidence map›Paper›PMID 22840822›Full record

ReviewJournal of chromatography. A2012

Advanced proteomic liquid chromatography.

Fang Xie, Richard D Smith, Yufeng Shen

Abstract readReview
In one paragraph

Review in Journal of chromatography. A, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Proteomic Advances in Cereal and Vegetable Crops.Molecules (Basel, Switzerland) · 2021
    Review
  8. Review
  9. Article
  10. Proteomic Profiling ofMolecules (Basel, Switzerland) · 2020
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fang XieBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.
Richard D Smith
Yufeng Shen

Funding

WORKSHOP AND TRAINING ACTIVITIESP41RR018522 · NCRR · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2003 to 2011
$25.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
PNNL Clinical Proteome Characterization CenterU24CA160019 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI RODLAND, KARIN D, SMITH, RICHARD D · 2011 to 2016
$15.7M
A Proteomics Platform for Quantitative, Ultra-High Throughput, and Ultra-SensitivR21CA126191 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2006 to 2007
$296k
NCI NIH HHS R21 CA126191NCI NIH HHS U24 CA160019NCI NIH HHS U24-CA-160019-01NCRR NIH HHS 5P41RR018522-10NCRR NIH HHS P41 RR018522NIGMS NIH HHS 8 P41 GM103493-10NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Liquid chromatography coupled with mass spectrometry is the predominant platform used to analyze proteomics samples consisting of large numbers of proteins and their proteolytic products (e.g., truncated polypeptides) and spanning a wide range of relative concentrations. This review provides an overview of advanced capillary liquid chromatography techniques and methodologies that greatly improve separation resolving power and proteomics analysis coverage, sensitivity, and throughput.

Indexed as

AnimalsChromatography, LiquidHumansPeptidesProteinsProteomicsPeptidesProteins

Identifiers

PMID22840822
PMCPMC3463731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.